Significados de chronic renal insufficiency em inglês

Anemia is commonly observed among subjects with chronic renal insufficiency.

Background: Cardiovascular disorders are the leading cause of death in patients with chronic renal insufficiency.

These findings require confirmation by a large randomized trial conducted specifically in people with chronic renal insufficiency.

Several recently published reports have advanced our understanding of the epidemiology of anemia associated with chronic renal insufficiency.

Background: A potentially modifiable risk factor for cardiovascular disease in patients with mild chronic renal insufficiency is dyslipidemia.

This raises the concern that such diets might exacerbate the lipid problems already prevalent in chronic renal insufficiency.

Two control groups were formed by healthy volunteers (C) and non-diabetic subjects with chronic renal insufficiency (RI).

Cardiovascular disease is the main cause of death for patients with chronic renal insufficiency, particularly in patients with ESRD.

Objective: To determine whether pravastatin is effective and safe for secondary prevention of cardiovascular events in persons with chronic renal insufficiency.

The Reference Sheets list the most common nutrition-related concerns for chronic renal insufficiency, hemodialysis, peritoneal dialysis, and post kidney transplant patients.

We suggest that until better evidence becomes available, patients with chronic renal insufficiency should generally let their thirst guide fluid intake.

Conclusion: Sustained high urine volume and low Uosm are independent risk factors for faster GFR decline in patients with chronic renal insufficiency.

This study was conducted to determine whether pravastatin reduced rates of loss of renal function in people with moderate chronic renal insufficiency.

Limited data suggest that HMG-CoA reductase inhibitors (statins) may slow loss of renal function in individuals with chronic renal insufficiency.

Among those with chronic renal insufficiency or end-stage renal disease, detection of dyslipidemia requires more careful analysis and knowledge of normal pediatric ranges.

Since statins may be underused in this setting, physicians should consider prescribing them for patients with chronic renal insufficiency and known coronary disease.